ArticlePLoS neglected tropical diseases2017

A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.

Mohamed Osman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.